Glucagon-like peptide 1-based drugs and pancreatic safety

JAMA Internal Medicine

Volumn 173, Issue 19, 2013, Pages 1842-1843

  Brodovicz, Kimberly G ^a   Engel, Samuel S ^a   Thornberry, Nancy A ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL PEPTIDASE IV INHIBITOR; GLUCAGON LIKE PEPTIDE 1; SITAGLIPTIN;

ACUTE PANCREATITIS; ALCOHOL CONSUMPTION; CASE CONTROL STUDY; DISEASE ASSOCIATION; DRUG SAFETY; HEALTH INSURANCE; HOSPITALIZATION; HUMAN; HYPERTRIGLYCERIDEMIA; LETTER; META ANALYSIS (TOPIC); NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PANCREAS CANCER; PHARMACOEPIDEMIOLOGY; PREDICTIVE VALUE; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REFERENCE DATABASE; RISK FACTOR; SIDE EFFECT; WEIGHT REDUCTION; CHEMICALLY INDUCED DISORDER; FEMALE; MALE; NOTE; PANCREATITIS;

DIABETES MELLITUS, TYPE 2; FEMALE; GLUCAGON-LIKE PEPTIDE 1; HOSPITALIZATION; HUMANS; MALE; PANCREATITIS;

EID: 84887053951     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2013.8138     Document Type: Letter

References (5)

1. Singh S, Chang HY, Richards TM, Weiner JP, Clark JM, Segal JB. Glucagonlike peptide 1-based therapies and risk of hospitalization for acute pancreatitis in type 2 diabetes mellitus: a population-based matched case-control study. JAMA Intern Med. 2013;173(7): 534-539.
2. Zhang Q, Rajagopalan S, Mavros P, et al. Baseline characteristic differences between patients prescribed sitagliptin vs other oral antihyperglycemic agents: analysis of a US electronic medical record database. Curr Med Res Opin. 2010;26(7): 1697-1703.
3. Engel SS, Williams-Herman DE, Golm GT, et al. Sitagliptin: review of preclinical and clinical data regarding incidence of pancreatitis. Int J Clin Pract. 2010;64(7): 984-990.
4. Monami M, Dicembrini I, Martelli D, Mannucci E. Safety of dipeptidyl peptidase-4 inhibitors: a meta-analysis of randomized clinical trials. Curr Med Res Opin. 2011;27(S3)(suppl 3): 57-64.
5. Garg R, Chen W, Pendergrass M. Acute pancreatitis in type 2 diabetes treated with exenatide or sitagliptin: a retrospective observational pharmacy claims analysis. Diabetes Care. 2010;33(11): 2349-2354.